Influenza virus is a highly variable virus. Most of its variability comes from the proteins on its surface, NA and HA. Current vaccines use these highly immunogenic proteins to induce production of neutralising antibodies, however because these proteins change from strain to strain, the antibody response is only efficient against the strain present in the vaccine and if the circulating strain is different to that in the deployed vaccine, it will not be protective.